Glycans are involved in a plethora of human pathologies including infectious diseases. Especially, glycosaminoglycans (GAGs), like heparan sulfate and chondroitin sulfate, have been found to be involved in different crucial stages of microbial invasion. Here, we review various therapeutic approaches, which target the interface of host GAGs and microbial proteins and discuss their limitations and challenges for drug development.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1042/BST20170485 | DOI Listing |
Publication Analysis
Top Keywords
therapeutic strategies
4
strategies target
4
target microbial
4
microbial protein-glycosaminoglycan
4
protein-glycosaminoglycan interactions
4
interactions glycans
4
glycans involved
4
involved plethora
4
plethora human
4
human pathologies
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!